| 英文名 | 7-nitro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione |
|---|---|
| 英文别名 |
5-aza-7-nitro-1,4-dihydroquinoxaline-2,3-dione
7-Nitro-1,4-dihydro-pyrido[2,3-b]pyrazine-2,3-dione |
| 分子式 | C7H4N4O4 |
|---|---|
| 分子量 | 208.13100 |
| 精确质量 | 208.02300 |
| PSA | 124.43000 |
| LogP | 0.04280 |
|
~79%
144435-09-6 |
| 文献：Ohmori; Kubota; Shimizu-Sasamata; Okada; Sakamoto Journal of Medicinal Chemistry, 1996 , vol. 39, # 6 p. 1331 - 1338 |
|
~71%
144435-09-6 |
| 文献：State of Oregon, acting by and through The Oregon State Board of Higher Education, acting for and on behalf of The Oregon Health Sciences University and The University of Oregon, Eugene Oregon; The Regents of the University of California; ACEA Pharmaceuticals, Inc. Patent: US5620978 A1, 1997 ; US 5620978 A |
|
~%
144435-09-6 |
| 文献：Cai, Sui Xiong; Huang, Jin-Cheng; Espitia, Stephen A.; Tran, Minhtam; Ilyin, Victor I.; Hawkinson, Jon E.; Woodward, Richard M.; Weber, Eckard; Keana, John F.W. Journal of Medicinal Chemistry, 1997 , vol. 40, # 22 p. 3679 - 3686 |
|
~%
144435-09-6 |
| 文献：Cai, Sui Xiong; Huang, Jin-Cheng; Espitia, Stephen A.; Tran, Minhtam; Ilyin, Victor I.; Hawkinson, Jon E.; Woodward, Richard M.; Weber, Eckard; Keana, John F.W. Journal of Medicinal Chemistry, 1997 , vol. 40, # 22 p. 3679 - 3686 |
